| AML | Acute myeloid leukaemia |
| AR | Androgen receptor |
| ATRA | All-trans retinoid acid |
| AURK | Aurora kinase |
| BC | Breast cancer |
| BCL2 | B-cell lymphoma 2 protein |
| BCL6 | B-cell lymphoma 6 protein |
| BCR | B-cell receptor |
| BDNF | Brain-derived neurotrophic factor |
| CDK9 | Cyclin-dependent kinase 9 |
| CREB | cAMP response element-binding protein |
| CRC | Colorectal cancer |
| CRISPRi | Clustered regularly interspaced short palindromic repeats interference |
| CRPC | Castration-resistant prostate cancer |
| CSCs | Cancer stem cells |
| CXCL12 | C-X-C motif chemokine 12 |
| DDK1 | Dickkopf-related protein 1 |
| DLBCL | Diffuse large B-cell lymphoma |
| EBV | Epstein-Barr virus |
| EpCAM | Epithelial cell adhesion molecule |
| EMT | Epithelial-mesenchymal transition |
| EPHB4 | Ephrin type-B receptor 4 (EPHB4 |
| Erα | Estrogen receptor |
| EZH1 | Enhancer of zeste homolog 1 |
| EZH2 | Enhancer of zeste homolog 2 |
| FAD | Flavin adenine dinucleotide |
| GC-B | Germinal center B |
| GSCs | Glioblastoma stem cells |
| GSK-J4 | Ethyl3-((6-(4:5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4 yl)amino)propanoate |
| endo-siRNAs | Endogenous short rnas |
| H3K27me3 | Tri methylation of lysine from histone 3 |
| HATs | Histone acetyltransferases |
| HDMs | Histone demethylases |
| HDACs | Histone deacetylases |
| hMSCs | Histone methyltransferases |
| HL | Hodgkin’s lymphoma |
| HTMs | Human mesenchymal stem cells |
| HSCs | Hematopoietic stem cells |
| IRF4 | Regulatory factor 4 interferon |
| JMJD3 | Jumonji Domain-Containing Protein 3 demethylase |
| KDM6B | Lysine-specific demethylase 6B |
| KLF2 | Kruppel Like Factor 2 |
| lnRNAs | Long non-coding rnas |
| LPS | Lipopolysaccharides |
| LMP1 | Latent membrane protein-1 |
| LSD1 | Lysine-specific demethylase 1 |
| MB | Medulloblastoma |
| MCL1 | Myeloid cell leukemia 1 |
| miRNA | micro rnas |
| MGMT | O—methylguanine-DNA methyltransferase |
| ncRNAs | Non-coding rnas |
| NOTCH1 | Notch receptor 1 |
| NOTCH2NL | Notch homolog 2 N-terminal-like |
| NOTCH3 | Notch receptor 3 |
| NK | Natural killer |
| NPM-ALK | Nucleophosmin-anaplastic lymphoma kinase |
| NSCLC | Non-small cell lung cancer epithelial-mesenchymal transition |
| OIS | Oncogene-induced senescence |
| PC | Prostate cancer |
| PCR1 | Polycomb repressive complex 1 |
| PCR2 | Polycomb repressive complex 2 |
| PGR | Progesterone receptor |
| PDGFRα | Platelet-derived growth factor receptor A |
| piRNAs | PIWI-interacting rnas |
| PTMs | Post-translational modifications |
| PUMA | p53 upregulated modulator of apoptosis |
| PKA | Protein kinase A |
| PZLF | Promyelocytic leukaemia zinc finger |
| RARβ2 | Retinoic acid receptor β2 |
| RGMA | Repulsive guidance molecule A |
| RPS6KA2 | Ribosomal protein S6 kinase A2 |
| RTK | Receptor tyrosine kinase |
| RUNX2 | Runt-related transcription factor 2 |
| S1PR1 | Sphingosine-1-Phosphate Receptor 1 |
| SNAI1 | Snail homolog 1 |
| STAT3 | Activator of transcription 3 |
| T-ALL | T-cell acute lymphoblastic leukaemia |
| TopoIIβ | Topoisomerase iiβ |
| TRA2A | Transformer 2 alpha homolog |
| U2AF1 | 2 small nuclear RNA auxiliary factor 1 |
| USP7 | Ubiquitin-specific peptidase 7 |
| UTX | Ubiquitously repeat transcribed tetratricopeptide repeat on the X chromosome |
| XIAP | X-linked inhibitor of apoptosis |
| ZEB1 | Zinc finger E-box-binding homeobox 1 |